₩6,000.00 ($4.46)

+20.00 (+0.33%)

Weekly Expected Move ±10.0%

₩4805 ₩5402 ₩6000 ₩6598 ₩7195

KOE · Healthcare · Medical - Specialties · Tech Score Neutral · Power 46 · ₩223.3B mcap · 26M float · 0.962% daily turnover

Revenue

$76.9B +12.2% ▲

5Y CAGR: +30.1%

Gross Profit

$33.7B +0.9% ▲

5Y CAGR: +33.3%

Operating Income

$3.8B -7.1% ▼

Net Income

-$7.4B -3852.5% ▼

EPS (Diluted)

$-206.64 -3821.1% ▼

EBITDA

$12.4B -20.0% ▼

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$33.2B	$46.0B	$58.7B	$68.5B	$76.9B
YoY Growth	+60.8%	+38.4%	+27.7%	+16.7%	+12.2%
Cost of Revenue	$19.1B	$25.5B	$30.4B	$35.1B	$43.2B
Gross Profit	$14.1B	$20.5B	$28.3B	$33.4B	$33.7B
Gross Margin	42.6%	44.5%	48.2%	48.8%	43.8%
R&D Expenses	$3.9B	$6.3B	$10.2B	$9.8B	$0
SG&A Expenses	$8.3B	$5.7B	$7.1B	$8.4B	$0
Operating Expenses	$11.9B	$18.3B	$25.7B	$29.3B	$29.9B
Operating Income	$2.3B	$4.0B	$2.6B	$4.1B	$3.8B
Operating Margin	6.9%	8.7%	4.5%	6.0%	5.0%
Interest Expense	$3.7B	$9.6B	$12.9B	$12.1B	$10.6B
Income Before Tax	$10.9B	$1.9B	$1.1B	-$5.7B	-$7.7B
Tax Expense	$0	$429M	-$12.5B	-$3.1B	-$253M
Net Income	$10.9B	$1.5B	$14.0B	-$188M	-$7.4B
Net Margin	32.8%	3.2%	23.8%	-0.3%	-9.7%
EPS (Diluted)	$303.00	$40.50	$67.50	$-5.27	$-206.64
EBITDA	$17.9B	$16.9B	$22.4B	$15.5B	$12.4B
Shares Outstanding	18M	18M	19M	36M	36M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$15.0B	$19.0B	$15.8B	$20.6B	$20.1B	$20.4B	$16.0B	$20.1B
Cost of Revenue	$6.8B	$13.2B	$8.7B	$9.9B	$11.0B	$13.6B	$7.9B	$10.7B
Gross Profit	$8.1B	$5.9B	$7.1B	$10.7B	$9.1B	$6.7B	$7.4B	$9.4B
Gross Margin	54.3%	30.8%	45.1%	52.0%	45.4%	33.1%	46.3%	46.9%
R&D Expenses	$1.7B	$2.9B	$0	$2.8B	$0	$2.7B	$2.2B	$2.2B
SG&A Expenses	$3.4B	-$114M	$2.1B	$8.9B	$8.1B	$2.0B	$2.6B	$4.8B
Operating Expenses	$7.9B	$5.9B	$7.3B	$8.9B	$8.1B	$5.6B	$8.8B	$7.1B
Operating Income	$244M	-$14M	-$144M	$1.8B	$1.0B	$1.2B	-$665M	$2.3B
Operating Margin	1.6%	-0.1%	-0.9%	8.6%	5.1%	5.8%	-4.2%	11.5%
Interest Expense	$2.9B	$3.2B	$3.1B	$3.2B	$3.0B	$1.2B	$2.1B	$1.9B
Income Before Tax	-$3.9B	$312M	-$4.1B	-$2.5B	-$3.2B	$2.1B	-$2.3B	$1.5B
Tax Expense	-$261M	-$3.0B	-$2M	-$78M	-$378M	$205M	$78M	$119M
Net Income	-$3.3B	$4.5B	-$3.7B	-$2.1B	-$3.1B	$2.3B	-$2.1B	$1.6B
Net Margin	-21.8%	23.8%	-23.1%	-10.4%	-15.3%	11.2%	-13.3%	7.9%
EPS (Diluted)	$-91.50	$126.49	$-102.36	$-59.84	$-85.77	$63.33	$-59.21	$42.83
EBITDA	$1.2B	$6.1B	$1.5B	$12.8B	$11.2B	$3.3B	$1.4B	$4.4B
Shares Outstanding	36M	36M	36M	36M	36M	36M	36M	37M

216080.KQ KOE